Page last updated: 2024-08-23

idarubicin and Tachycardia, Supraventricular

idarubicin has been researched along with Tachycardia, Supraventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aul, C; Bauser, U; Fischer, J; Frick, M; Heyll, A; Kobbe, G; Quenzel, EM; Rieth, C; Schneider, P; Söhngen, D; Südhoff, T; Thiele, KP; Wehmeier, A; Wernet, P1
Ahn, YK; Cho, JG; Chung, IJ; Kim, HJ; Lee, JJ; Park, MR; Shin, DH1

Trials

1 trial(s) available for idarubicin and Tachycardia, Supraventricular

ArticleYear
Idarubicin, melphalan and cyclophosphamide: an intensified high-dose regimen for the treatment of myeloma patients.
    Leukemia, 1997, Volume: 11 Suppl 5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Idarubicin; Male; Melphalan; Middle Aged; Multiple Myeloma; Neoplasm Staging; Tachycardia, Supraventricular

1997

Other Studies

1 other study(ies) available for idarubicin and Tachycardia, Supraventricular

ArticleYear
Life-threatening paroxysmal supraventricular tachycardia developed during granulocyte transfusion therapy for neutropenia-related infection.
    Leukemia, 2000, Volume: 14, Issue:7

    Topics: Adult; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Citrates; Cytarabine; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Idarubicin; Infections; Leukapheresis; Leukemia, Erythroblastic, Acute; Leukocyte Transfusion; Male; Neutropenia; Sodium Citrate; Tachycardia, Supraventricular

2000